Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Cognitive training: a complex field

Etienne de Villers-Sidani • 4 Sep 2017
AAIC 2017
Mild Cognitive Impairment

Etienne de Villers-Sidani, MD from the Montreal Neurological Institute, Montreal, Canada talks to us about the complicated nature of cognitive training. It is still not clearly understood how this therapy is able to benefit patients, and Dr de Villers-Sidani explains how uncovering this is key to providing personalized treatment tailored to each patient. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.

More from Etienne de Villers-Sidani

Training to compensate for cognitive decline
1:46
Training to compensate for cognitive decline
Etienne de Villers-Sidani • 4 Sep 2017
The complicated relationship between technology and cognitive training
1:54
The complicated relationship between technology and cognitive training
Etienne de Villers-Sidani • 4 Sep 2017
Stimulating strategies to study cognition
1:37
Stimulating strategies to study cognition
Etienne de Villers-Sidani • 17 Jul 2017
Brain changes and cognitive training
1:15
Brain changes and cognitive training
Etienne de Villers-Sidani • 17 Jul 2017

Related Videos

What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026
The association between sleep disturbance and amyloid and tau pathology in Alzheimer's disease
3:06
The association between sleep disturbance and amyloid and tau pathology in Alzheimer's disease
Omonigho Michael Bubu • 13 Jul 2026
Clinical application of plasma p-tau217 in cognitively unimpaired individuals
1:51
Clinical application of plasma p-tau217 in cognitively unimpaired individuals
Rachel Buckley • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals